loading
前日終値:
$10.48
開ける:
$10.48
24時間の取引高:
3.94M
Relative Volume:
0.78
時価総額:
$7.73B
収益:
$125.68M
当期純損益:
$4.81B
株価収益率:
1.8372
EPS:
5.65
ネットキャッシュフロー:
$-781.21M
1週間 パフォーマンス:
-3.80%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
-9.58%
1年 パフォーマンス:
-1.52%
1日の値動き範囲:
Value
$10.29
$10.53
1週間の範囲:
Value
$10.29
$10.90
52週間の値動き範囲:
Value
$10.00
$13.05

Roivant Sciences Ltd Stock (ROIV) Company Profile

Name
名前
Roivant Sciences Ltd
Name
セクター
Healthcare (1166)
Name
電話
441-295-5950
Name
住所
CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM11
Name
職員
0
Name
Twitter
Name
次回の収益日
2025-02-10
Name
最新のSEC提出書
Name
ROIV's Discussions on Twitter

ROIV を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ROIV
Roivant Sciences Ltd
10.38 7.73B 125.68M 4.81B -781.21M 5.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-02-15 開始されました Wolfe Research Outperform
2024-01-05 開始されました Piper Sandler Overweight
2023-12-12 開始されました Deutsche Bank Buy
2023-10-17 開始されました Guggenheim Buy
2023-06-08 開始されました BofA Securities Neutral
2022-10-27 開始されました JP Morgan Overweight
2022-05-23 開始されました SVB Leerink Outperform
2022-04-29 開始されました Cantor Fitzgerald Overweight
2021-12-15 開始されました Goldman Buy
2021-11-08 開始されました H.C. Wainwright Buy
2021-10-28 開始されました Citigroup Buy
2021-10-26 開始されました Cowen Outperform
2021-10-26 開始されました Jefferies Buy
2021-10-26 開始されました Truist Buy
すべてを表示

Roivant Sciences Ltd (ROIV) 最新ニュース

pulisher
Mar 25, 2025

Is Roivant Sciences Ltd. (NASDAQ:ROIV) One of The Best Stocks to Buy According to Billionaire David Einhorn? - Yahoo Finance

Mar 25, 2025
pulisher
Mar 24, 2025

Roivant Sciences president Eric Venker sells shares worth $8.19 million - Investing.com

Mar 24, 2025
pulisher
Mar 23, 2025

Immunovant, Roivant slip after trial data for autoimmune disorder therapy - MSN

Mar 23, 2025
pulisher
Mar 23, 2025

(ROIV) Trading Advice - Stock Traders Daily

Mar 23, 2025
pulisher
Mar 20, 2025

Roivant Sciences finalizes consulting agreement with former officer - Investing.com India

Mar 20, 2025
pulisher
Mar 19, 2025

Roivant Phase III Batoclimab Trial Is Positive, But No Filing Planned - News & Insights

Mar 19, 2025
pulisher
Mar 19, 2025

Roivant Sciences Says Phase 3 MG Study Meets Primary Endpoint -March 19, 2025 at 08:24 am EDT - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Roivant Sciences Announces Positive Results for Batoclimab Studies - TipRanks

Mar 19, 2025
pulisher
Mar 12, 2025

(ROIV) Trading Signals - Stock Traders Daily

Mar 12, 2025
pulisher
Mar 11, 2025

Roivant at Leerink’s Conference: Strategic Insights and Developments By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 07, 2025

Does Roivant (ROIV) Offer an Attractive Risk Reward Opportunity? - Insider Monkey

Mar 07, 2025
pulisher
Mar 04, 2025

10 Cash-Rich Mid Cap Stocks To Buy Now - Insider Monkey

Mar 04, 2025
pulisher
Mar 03, 2025

Roivant Sciences Ltd. (ROIV): Among the Cash-Rich Mid Cap Stocks to Buy Now - Insider Monkey

Mar 03, 2025
pulisher
Mar 02, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Bought by New York State Common Retirement Fund - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Trend Tracker for (ROIV) - Stock Traders Daily

Mar 01, 2025
pulisher
Feb 28, 2025

Principal Financial Group Inc. Lowers Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Handelsbanken Fonder AB Trims Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Net worth of Vivek Ramaswamy: Roviant Sciences founder who is running for Ohio governor - The Times of India

Feb 27, 2025
pulisher
Feb 25, 2025

Early Warning Report Issued Pursuant to National Instrument 62‐103: Roivant announces Resignation and Replacement of Arbutus Board - The Manila Times

Feb 25, 2025
pulisher
Feb 25, 2025

Early Warning Report Issued Pursuant to National Instrument 62?103: Roivant announces Resignation and Replacement of Arbutus Board - Lelezard

Feb 25, 2025
pulisher
Feb 24, 2025

Roivant Sciences president Eric Venker sells $1.07 million in shares - Investing.com India

Feb 24, 2025
pulisher
Feb 21, 2025

Roivant Sciences appoints new Principal Accounting Officer By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

Roivant Sciences appoints new Principal Accounting Officer - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

Roivant Sciences Appoints New Chief Accounting Officer - TipRanks

Feb 21, 2025
pulisher
Feb 20, 2025

Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So. - The Motley Fool

Feb 20, 2025
pulisher
Feb 19, 2025

Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) CAO Sells 227,500 Shares of Stock - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Long Term Trading Analysis for (ROIV) - Stock Traders Daily

Feb 19, 2025
pulisher
Feb 19, 2025

Roivant Sciences’ chief accounting officer sells $2.37 million in shares - Investing.com India

Feb 19, 2025
pulisher
Feb 18, 2025

Roivant Sciences' chief accounting officer sells $2.37 million in shares By Investing.com - Investing.com Canada

Feb 18, 2025
pulisher
Feb 18, 2025

Roivant Sciences’ chief accounting officer sells $2.37 million in shares By Investing.com - Investing.com Nigeria

Feb 18, 2025
pulisher
Feb 18, 2025

Roivant Sciences' chief accounting officer sells $2.37 million in shares - Investing.com

Feb 18, 2025
pulisher
Feb 18, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) COO Eric Venker Sells 218,041 Shares - MarketBeat

Feb 18, 2025
pulisher
Feb 16, 2025

Roivant Sciences president Eric Venker sells over $4.56 million in stock - MSN

Feb 16, 2025
pulisher
Feb 15, 2025

Roivant Sciences president Eric Venker sells over $4.56 million in stock By Investing.com - Investing.com South Africa

Feb 15, 2025
pulisher
Feb 14, 2025

Roivant Sciences (NASDAQ:ROIV) Shares Gap Up After Earnings Beat - MarketBeat

Feb 14, 2025
pulisher
Feb 13, 2025

178,853 Shares in Roivant Sciences Ltd. (NASDAQ:ROIV) Acquired by Elevate Capital Advisors LLC - MarketBeat

Feb 13, 2025

Roivant Sciences Ltd (ROIV) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Roivant Sciences Ltd (ROIV) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Venker Eric
President & COO
Mar 20 '25
Option Exercise
3.85
400,000
1,540,000
1,274,979
Venker Eric
President & COO
Mar 24 '25
Sale
10.82
434,478
4,701,052
1,127,290
Venker Eric
President & COO
Mar 20 '25
Sale
11.06
315,522
3,489,673
959,457
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
大文字化:     |  ボリューム (24 時間):